title: Does salmeterol increase mortality in patients with COPD?
authors.affiliation: Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: R B
authors.initials: RB
authors.lastname: Gerber
authors.forename: M
authors.initials: M
authors.lastname: Kavuru
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives*; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000401:mortality*; D000068299:Salmeterol Xinafoate; D015996:Survival Rate
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000068299:Salmeterol Xinafoate; D000420:Albuterol